These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7908384)

  • 1. TEM-1 plasmids in the community.
    Thomson CJ; Shanahan PM; Amyes SG
    Lancet; 1994 Apr; 343(8902):921. PubMed ID: 7908384
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.
    Thomson CJ; Amyes SG
    Epidemiol Infect; 1993 Feb; 110(1):117-25. PubMed ID: 8432315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissemination of the TEM-I beta-lactamase gene into disparate plasmids in faecal strains of Escherichia coli isolated in Vellore, south India.
    Thomson CJ; Tait S; Jesudason MV; Amyes SG
    J Infect; 1993 Jul; 27(1):47-50. PubMed ID: 8370945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OHIO-1 beta-lactamase resistant to mechanism-based inactivators.
    Bonomo RA; Currie-McCumber C; Shlaes DM
    FEMS Microbiol Lett; 1992 Apr; 71(1):79-82. PubMed ID: 1320587
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli.
    Woodford N; Payne DJ; Johnson AP; Weinbren MJ; Perinpanayagam RM; George RC; Cookson BD; Amyes SG
    Lancet; 1990 Jul; 336(8709):253. PubMed ID: 1973805
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput transformation and plating using petristrips.
    McNulty JJ; Dunn JJ
    Biotechniques; 1999 Mar; 26(3):390-2. PubMed ID: 10090970
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmid-mediated beta-lactam resistance in pathogenic gram-negative bacteria isolated in south India.
    Nandivada LS; Amyes SG
    J Antimicrob Chemother; 1990 Aug; 26(2):279-90. PubMed ID: 2211459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli resistant to ampicillin/sulbactam.
    Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
    Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of antibiotic-inactivating enzymes and DNA probes: the problem of quantity.
    Martinez JL; Baquero F
    J Antimicrob Chemother; 1990 Sep; 26(3):301-3. PubMed ID: 2228821
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain.
    Thomson CJ; Amyes SG
    FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the beta-lactamase resistance to clavulanic acid.
    Saves I; Burlet-Schiltz O; Swarén P; Lefèvre F; Masson JM; Promé JC; Samama JP
    J Biol Chem; 1995 Aug; 270(31):18240-5. PubMed ID: 7629142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
    Weber DA; Sanders CC; Bakken JS; Quinn JP
    J Infect Dis; 1990 Aug; 162(2):460-5. PubMed ID: 2197339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperproduction of TEM-1 beta-lactamase by Escherichia coli strains.
    Page JW; Farmer TH; Elson SW
    J Antimicrob Chemother; 1989 Jan; 23(1):160-1. PubMed ID: 2663805
    [No Abstract]   [Full Text] [Related]  

  • 18. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
    Aubert G; Peyle V; Dumont N; el Fassi M; Dorche G
    Ann Biol Clin (Paris); 1990; 48(7):449-54. PubMed ID: 2278408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N; Thomson CJ; Amyes SG; Stobberingh E
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.